Clinical Trial Update: Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating sodium bicarbonate and lipocalin as interventions for systemic inflammatory response syndrome with oliguria and renal impairm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Lipocalin (lipocalin)
• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Austin Health | Conditions: Systemic Inflammatory Response Syndrome, Oliguria | Phase 2 | Status: COMPLETED